Akne-mycin
Loading...Akne-mycin Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
The safe use of Akne-mycin during pregnancy or lactation has not been established.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Akne-mycin is indicated for topical control of acne vulgaris.
History
There is currently no drug history available for this drug.
Other Information
Akne-mycin (erythromycin) topical ointment contains erythromycin which is produced from a strain of Streptomyces erythraeus. Each gram of Akne-mycin topical ointment contains 20 mg of erythromycin base in a vehicle consisting of mineral oil, petrolatum, paraffin, talc, titanium dioxide, trilaureth 4 phosphate, oleyl oleate, tricetareth 4 phosphate, cetostearyl alcohol and sorbitol. Akne-mycin marketed in the United States is not of the same composition as Akne-mycin marketed in Europe.
Sources
Akne-mycin Manufacturers
-
Coria Laboratories
![Akne-mycin (Erythromycin) Ointment [Coria Laboratories]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Akne-mycin | Coria Laboratories
Akne-mycin should be applied to the affected area twice daily, morning and evening.
Login To Your Free Account